IQVIA Holdings Inc. logo

IQVIA Holdings Inc. (IQV)

Market Open
16 Oct, 01:59 PM
NYSE NYSE
$
271. 24
+0.19
+0.0719%
$
42.91B Market Cap
38.04 P/E Ratio
- Div Yield
94,441 Volume
10.19 Eps
$ 271.04
Previous Close
Add Transaction
Day Range
270.07 273.1
Year Range
154.5 277.4
Want to track IQV and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
IQVIA Holdings Inc. (IQV) Q2 2026 Earnings Call Transcript

IQVIA Holdings Inc. (IQV) Q2 2026 Earnings Call Transcript

IQVIA Holdings Inc. (IQV) Q2 2026 Earnings Call Transcript

Seekingalpha | 2 months ago
IQVIA Q2 Earnings Call Highlights

IQVIA Q2 Earnings Call Highlights

IQVIA NYSE: IQV reported second-quarter results that exceeded the high end of its guidance, supported by accelerating organic revenue growth, higher R&D Solutions bookings and operational productivity gains. The company also raised its full-year outlook for revenue, adjusted EBITDA and adjusted diluted earnings per share.

Marketbeat | 2 months ago
IQV Q2 Earnings Beat Estimates on R&D Bookings, Guidance Raised

IQV Q2 Earnings Beat Estimates on R&D Bookings, Guidance Raised

IQVIA's Q2 earnings beat estimates as record R&D bookings, broad-based growth and stronger demand support a raised 2026 outlook.

Zacks | 2 months ago
IQVIA Holdings (IQV) Q2 Earnings and Revenues Beat Estimates

IQVIA Holdings (IQV) Q2 Earnings and Revenues Beat Estimates

IQVIA Holdings (IQV) came out with quarterly earnings of $3.15 per share, beating the Zacks Consensus Estimate of $3.02 per share. This compares to earnings of $2.81 per share a year ago.

Zacks | 2 months ago
IQVIA Gears Up to Report Q2 Earnings: What's in the Offing?

IQVIA Gears Up to Report Q2 Earnings: What's in the Offing?

IQV heads into its Q2'26 earnings release with y/y revenue and EPS growth expected, supported by AI adoption, drug launches and high-margin segment gains.

Zacks | 2 months ago
IQVIA Holdings (IQV) Reports Next Week: Wall Street Expects Earnings Growth

IQVIA Holdings (IQV) Reports Next Week: Wall Street Expects Earnings Growth

IQVIA (IQV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 2 months ago
IQV vs. PEN: Which Stock Is the Better Value Option?

IQV vs. PEN: Which Stock Is the Better Value Option?

Investors interested in stocks from the Medical - Instruments sector have probably already heard of IQVIA Holdings (IQV) and Penumbra (PEN). But which of these two stocks is more attractive to value investors?

Zacks | 3 months ago
Here's Why IQVIA Holdings (IQV) is a Strong Value Stock

Here's Why IQVIA Holdings (IQV) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 3 months ago
Here's Why Investors Should Hold IQV Stock in Their Portfolios Now

Here's Why Investors Should Hold IQV Stock in Their Portfolios Now

IQVIA's AI tools, record R&D backlog and strong free cash flow support its outlook, but weak liquidity and no dividend remain investor concerns.

Zacks | 3 months ago
Why IQVIA Holdings (IQV) is a Top Value Stock for the Long-Term

Why IQVIA Holdings (IQV) is a Top Value Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 4 months ago
Here's Why IQVIA Holdings (IQV) is a Strong Momentum Stock

Here's Why IQVIA Holdings (IQV) is a Strong Momentum Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 4 months ago
IQVIA (IQV) Up 3.2% Since Last Earnings Report: Can It Continue?

IQVIA (IQV) Up 3.2% Since Last Earnings Report: Can It Continue?

IQVIA (IQV) reported earnings 30 days ago. What's next for the stock?

Zacks | 4 months ago
Loading...
Load More